Download presentation
Presentation is loading. Please wait.
Published byVictor Norton Modified over 9 years ago
1
Prognostic Factors in Breast Cancer; Many Identified; Examples: Node status Tumour size Histologic grade Estrogen receptor Progesterone receptor IGF-IR Marrow micromets ErbB-2 expression EGF-R TP53 mutations Cathepsin D Telomerase activity PAI-1 level
2
ERBB2 GRB7 TNF-receptor-associated factor 4 TGFB1-induced anti-apoptotic factor 1 Cadherin 3 Laminin keratin 17 keratin 5 troponin I TGF beta 2 GRO1 oncogene, alpha CD36 antigen collagen glutathione peroxidase 3 plasma lipoprotein lipase integrin, alpha 7 retinol-binding protein 4 Putative G-coupled receptor Estrogen receptor trefoil factor 3 GATA-binding protein 3 X-box binding protein 1 LIV-1 NAT1 arylamine transferrin receptor p90 V-myb homolog integral membrane transporter hydrolase conjugase nucleolar protein p40 Nature 406:747-752,2000 PNAS 98:10869-10874, 2001
3
”Survival or RFS ”endpoints” ”Metastatic potential” ”Therapy effect” ”Growth rate” Lymph node status TP53 Mutations
4
Cell cycle Cyclins ( cyc D) and a cdk (like cdk4/cdk6) complex Acting in different phases of the cycle Influenced by inhibitors (p16, p21, p27, p57) Amplifications – mutations Influenced by upstream GF / Oncogenes Some genes involved in cell cycle control (sometimes at G1 as well as G2) also involved in apoptosis (p53) Therapy effects; growth arrest / apoptosis poorly understood
5
X1 X2 X3 X4 Y2 Y1 Z1 Z2 Z3 Y11 Y21 Z11 Z21 Z31 D1 D12 D2 D21 D22 D23 D3 D31 G1 G2 G3 G11 G111 G21 G31
6
X1 X2 X3 X4 Y2 Y1 Z1 Z2 Z3 Y11 Y21 Z11 Z21 Z31 D1 D12 D2 D21 D22 D23 D3 D31 G1 G2 G3 G11 G111 G21 G31 Y1 Y2 Y3
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.